Corneal epithelial defect
Conditions
Interventions
Experimental group:Long acting corneal protectant
Control group:The 'corneal protector' produced by Valeant Med Sp.zo.o.
Sponsors
Eye Hospital of Shandong First Medical University (Shandong Eye Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients undergoing ophthalmic surgery who require corneal epithelial protection; 2.Subjects aged 18 to 80 years, with no gender restriction; 3.Subjects who voluntarily agree to participate in this clinical trial and have signed the Informed Consent Form (ICF).
Exclusion criteria
Exclusion criteria: 1.Patients who have participated in other clinical trials within the past one month; 2.Pregnant or lactating women; 3.Patients with a known hypersensitivity to hypromellose; 4.Patients with corneal, conjunctival, eyelid, or lacrimal duct diseases; 5.Patients with diabetes mellitus; 6.Patients with severe dry eye in the operative eye; 7.Patients with a Schirmer I test result of 0 in the operative eye 8.Patients with a history of corneal trauma in the operative eye; 9.Patients who have undergone ophthalmic surgery in the operative eye within the past three months; 10.Patients who, in the investigator’s opinion, are unsuitable for enrollment due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corneal fluorescein staining;Break-up Time;Success rate of optical clarity maintenance;Schirmer I test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Product optical clarity retention time;Instillation frequency;Dosage per instillation; | — |
Countries
China
Contacts
Public ContactWang Ting
Eye Hospital of Shandong First Medical University (Shandong Eye Hospital)
Outcome results
None listed